Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -465.42% is 267% below its 5-year average of -126.73%, near the high end of its 5-year range (-5192.87%–-52.64%).
78.10% above its 12-month average of -2125.52%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -897.06%.
OPERATING MARGIN
-465.42%
OPERATING MARGIN AVG TTM
-2125.52%
OPERATING MARGIN AVG 3Y
-364.66%
OPERATING MARGIN AVG 5Y
-126.73%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+78.10%
CURRENT VS 3Y AVG
-27.63%
CURRENT VS 5Y AVG
-267.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
iSpecimen Inc.
Market Cap
$2.69M
Operating Margin
-465.42%
TTM Avg
-2125.52%
3Y Avg
-364.66%
5Y Avg
-126.73%
Market Cap
$2.66M
Operating Margin
-16.33%
TTM Avg
-25.58%
3Y Avg
-19.89%
5Y Avg
-2.98%
Market Cap
$2.56M
Operating Margin
-140.62%
TTM Avg
-130.00%
3Y Avg
-164.97%
5Y Avg
-189.21%
Market Cap
$2.54M
Operating Margin
-171.58%
TTM Avg
-133.61%
3Y Avg
-21023.40%
5Y Avg
-14015.60%
Market Cap
$2.86M
Operating Margin
-446.70%
TTM Avg
-461.82%
3Y Avg
-487.15%
5Y Avg
-381.78%
Market Cap
$2.94M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.44M
Operating Margin
-391.87%
TTM Avg
-327.81%
3Y Avg
-323.70%
5Y Avg
-419.63%
Market Cap
$2.38M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.38M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iSpecimen Inc. (ISPC) | $2.69M | -465.42% | -2125.52% | -364.66% | -126.73% |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.66M | -16.33% | -25.58% | -19.89% | -2.98% |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | -140.62% | -130.00% | -164.97% | -189.21% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | -171.58% | -133.61% | -21023.40% | -14015.60% |
| IceCure Medical Ltd (ICCM)vs › | $2.86M | -446.70% | -461.82% | -487.15% | -381.78% |
| Revelation Biosciences, Inc. (REVB)vs › | $2.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| Jaguar Health, Inc. (JAGX)vs › | $2.44M | -391.87% | -327.81% | -323.70% | -419.63% |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| Onconetix, Inc. (ONCO)vs › | $2.37M | -778.16% | -1508.06% | -16162.65% | -10775.10% |
Gross Margin
1.3%
Operating Margin
-465.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -897.06% |
| 2026-03-31 | -1627.09% |
| 2025-12-31 | -5192.87% |
| 2025-09-30 | -2655.19% |
| 2025-06-30 | -255.41% |
| 2025-03-31 | -154.93% |
| 2024-12-31 | -395.83% |
| 2024-09-30 | -64.07% |
| 2024-06-30 | -76.18% |
| 2024-03-31 | -131.03% |
| 2023-12-31 | -111.49% |
| 2023-09-30 | -78.99% |
| 2023-06-30 | -219.17% |
| 2023-03-31 | -86.18% |
| 2022-12-31 | -72.31% |
| 2022-09-30 | -120.04% |
| 2022-06-30 | -110.53% |
| 2022-03-31 | -93.64% |
| 2021-12-31 | -78.26% |
| 2021-09-30 | -53.67% |
| 2021-06-30 | -52.64% |
| 2021-03-31 | -31.81% |
| 2020-12-31 | -34.38% |
| 2020-09-30 | -32.13% |
| 2020-06-30 | -20.27% |
| 2020-03-31 | -26.03% |
| 2019-12-31 | -55.59% |
| 2019-09-30 | -221.24% |
